Key statistics
As of last trade, Marinus Pharmaceuticals Inc (61Y:BER) traded at 1.61, 64.29% above the 52 week low of 0.98 set on Aug 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.62 |
---|---|
High | 1.62 |
Low | 1.61 |
Bid | 1.52 |
Offer | 1.71 |
Previous close | 1.62 |
Average volume | 900.00 |
---|---|
Shares outstanding | 55.08m |
Free float | 54.56m |
P/E (TTM) | -- |
Market cap | 98.05m USD |
EPS (TTM) | -2.66 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 10:58 BST.
More ▼
Press releases
- Marinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst Day
- Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024
- Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference
- Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024
- Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results
- Ligand Reports Second Quarter 2024 Financial Results
- Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2024 Financial Results on August 13, 2024
- Marinus Pharmaceuticals Announces Ganaxolone Approved in China as First Treatment for Seizures Associated with CDKL5 Deficiency Disorder
More ▼